KSHV Immune Evasion

  • Chengyu Liang
  • Hyera Lee
  • Liguo Wu
  • Pinghui Feng
  • Jae U. Jung


Kaposi’s sarcoma-associated herpesvirus (KSHV) has been consistently implicated in the pathogenesis of Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman’s disease (MCD). The hallmark of KSHV infection is to establish life-long persistency that has imposed enormous pressure on this virus to escape host immune recognition. Although many of the mechanistic details require further elucidation, KSHV devotes a significant portion of its genome to gene products that together sabotage almost every aspect of host’s immune system. A more thorough understanding of these strategies helps to unravel the complexities of viral pathogenesis and may reveal targets for novel therapeutic strategies. This review provides an overview of the current understanding of how KSHV evades or mitigates the host immune response.


Natural Killer Cell Herpes Simplex Virus KSHV Infection Primary Effusion Lymphoma Cell Viral Immune Evasion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Albrecht, J. C., and B. Fleckenstein. 1992. New member of the multigene family of complement control proteins in herpesvirus saimiri. J Virol 66:3937–40.PubMedGoogle Scholar
  2. 2.
    Alcami, A., and U. H. Koszinowski. 2000. Viral mechanisms of immune evasion. Trends Microbiol 8:410–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Alexander, L., L. Denekamp, A. Knapp, M. R. Auerbach, B. Damania, and R. C. Desrosiers. 2000. The primary sequence of rhesus monkey rhadinovirus isolate 26–95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J Virol 74:3388–98.PubMedCrossRefGoogle Scholar
  4. 4.
    Altmann, M., and W. Hammerschmidt. 2005. Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol 3:e404.PubMedCrossRefGoogle Scholar
  5. 5.
    Ambagala, A. P., J. C. Solheim, and S. Srikumaran. 2005. Viral interference with MHC class I antigen presentation pathway: the battle continues. Vet Immunol Immunopathol 107:1–15.PubMedCrossRefGoogle Scholar
  6. 6.
    Ankel, H., M. R. Capobianchi, F. Frezza, C. Castilletti, and F. Dianzani. 1996. Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. Virology 221:113–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Ankel, H., D. F. Westra, S. Welling-Wester, and P. Lebon. 1998. Induction of interferon-alpha by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology 251:317–26.PubMedCrossRefGoogle Scholar
  8. 8.
    Arico, S., A. Petiot, C. Bauvy, P. F. Dubbelhuis, A. J. Meijer, P. Codogno, and E. Ogier-Denis. 2001. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 276:35243–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Arkadiusz Welman, C. C., Jane Barraclough, Nigel Smith, Gareth J.Griffiths, Rachel L. Cowen, Judith C.Willians, Ian J.Stratford, and Caroline Dive. 2005. Construction and Characterization of Multiple Human Colon Cancer Cell Lines for Inducibly Regulated Gene Expression. Journal of Cellular Biochemistry 94:1148–1162.PubMedCrossRefGoogle Scholar
  10. 10.
    Arvanitakis, L., E. Geras-Raaka, A. Varma, M. C. Gershengorn, and E. Cesarman. 1997. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347–50.PubMedCrossRefGoogle Scholar
  11. 11.
    Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392:565–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Bais, C., B. Santomasso, O. Coso, L. Arvanitakis, E. G. Raaka, J. S. Gutkind, A. S. Asch, E. Cesarman, M. C. Gershengorn, and E. A. Mesri. 1998. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Bellows, D. S., B. N. Chau, P. Lee, Y. Lazebnik, W. H. Burns, and J. M. Hardwick. 2000. Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol 74:5024–31.PubMedCrossRefGoogle Scholar
  14. 14.
    Bertin, J., R. C. Armstrong, S. Ottilie, D. A. Martin, Y. Wang, S. Banks, G. H. Wang, T. G. Senkevich, E. S. Alnemri, B. Moss, M. J. Lenardo, K. J. Tomaselli, and J. I. Cohen. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci U S A 94:1172–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Boehme, K. W., J. Singh, S. T. Perry, and T. Compton. 2004. Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J Virol 78:1202–11.PubMedCrossRefGoogle Scholar
  16. 16.
    Boshoff, C., Y. Endo, P. D. Collins, Y. Takeuchi, J. D. Reeves, V. L. Schweickart, M. A. Siani, T. Sasaki, T. J. Williams, P. W. Gray, P. S. Moore, Y. Chang, and R. A. Weiss. 1997. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278:290–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Boulanger, M. J., D. C. Chow, E. Brevnova, M. Martick, G. Sandford, J. Nicholas, and K. C. Garcia. 2004. Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6. J Mol Biol 335:641–54.PubMedCrossRefGoogle Scholar
  18. 18.
    Bower, J. F., T. D. Green, and T. M. Ross. 2004. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Virology 328:292–300.PubMedCrossRefGoogle Scholar
  19. 19.
    Bridgeman, A., P. G. Stevenson, J. P. Simas, and S. Efstathiou. 2001. A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load. J Exp Med 194:301–12.PubMedCrossRefGoogle Scholar
  20. 20.
    Bryceson, Y. T., M. E. March, H. G. Ljunggren, and E. O. Long. 2006. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 214:73–91.PubMedCrossRefGoogle Scholar
  21. 21.
    Burysek, L., W. S. Yeow, B. Lubyova, M. Kellum, S. L. Schafer, Y. Q. Huang, and P. M. Pitha. 1999. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 73:7334–42.PubMedGoogle Scholar
  22. 22.
    Cadwell, K., and L. Coscoy. 2005. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309:127–30.PubMedCrossRefGoogle Scholar
  23. 23.
    Cebulla, C. M., D. M. Miller, and D. D. Sedmak. 1999. Viral inhibition of interferon signal transduction. Intervirology 42:325–30.PubMedCrossRefGoogle Scholar
  24. 24.
    Cesarman, E., E. A. Mesri, and M. C. Gershengorn. 2000. Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? J Exp Med 191:417–22.PubMedCrossRefGoogle Scholar
  25. 25.
    Cesarman, E., R. G. Nador, F. Bai, R. A. Bohenzky, J. J. Russo, P. S. Moore, Y. Chang, and D. M. Knowles. 1996. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 70:8218–23.PubMedGoogle Scholar
  26. 26.
    Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Chatterjee, M., J. Osborne, G. Bestetti, Y. Chang, and P. S. Moore. 2002. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Chaudhary, P. M., A. Jasmin, M. T. Eby, and L. Hood. 1999. Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18:5738–46.PubMedCrossRefGoogle Scholar
  29. 29.
    Chen, D., and J. Nicholas. 2006. Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6. J Virol 80:9811–21.PubMedCrossRefGoogle Scholar
  30. 30.
    Chen, J., K. Ueda, S. Sakakibara, T. Okuno, and K. Yamanishi. 2000. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene. J Virol 74:8623–34.PubMedCrossRefGoogle Scholar
  31. 31.
    Cheng, E. H., J. Nicholas, D. S. Bellows, G. S. Hayward, H. G. Guo, M. S. Reitz, and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 94:690–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Chengyu Liang, P. F., Bonsu Ku, Iris Dotan, Dan Canaani, Byung-Ha Oh, and Jae U. Jung. 2006. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG Nature Cell Biology 8:688–699.Google Scholar
  33. 33.
    Chugh, P., H. Matta, S. Schamus, S. Zachariah, A. Kumar, J. A. Richardson, A. L. Smith, and P. M. Chaudhary. 2005. Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc Natl Acad Sci U S A 102:12885–90.PubMedCrossRefGoogle Scholar
  34. 34.
    Chung, Y. H., R. E. Means, J. K. Choi, B. S. Lee, and J. U. Jung. 2002. Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J Virol 76:4688–98.PubMedCrossRefGoogle Scholar
  35. 35.
    Coscoy, L., and D. Ganem. 2001. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest 107:1599–606.PubMedCrossRefGoogle Scholar
  36. 36.
    Coscoy, L., and D. Ganem. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A 97:8051–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Coscoy, L., and D. Ganem. 2003. PHD domains and E3 ubiquitin ligases: viruses make the connection. Trends Cell Biol 13:7–12.PubMedCrossRefGoogle Scholar
  38. 38.
    Coscoy, L., D. J. Sanchez, and D. Ganem. 2001. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J Cell Biol 155:1265–73.PubMedCrossRefGoogle Scholar
  39. 39.
    Cuconati A, D. K., Sundararajan R, Anschel A, White E. 2002. Bak and Bax function to limit adenovirus replication through apoptosis induction. Journal of Virology 76:4547–4558PubMedCrossRefGoogle Scholar
  40. 40.
    Cuconati A, W. E. 2002. Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Development 16:2465–2478.PubMedCrossRefGoogle Scholar
  41. 41.
    Cunningham, C., S. Barnard, D. J. Blackbourn, and A. J. Davison. 2003. Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. J Gen Virol 84:1471–83.PubMedCrossRefGoogle Scholar
  42. 42.
    Dairaghi, D. J., R. A. Fan, B. E. McMaster, M. R. Hanley, and T. J. Schall. 1999. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J Biol Chem 274:21569–74.PubMedCrossRefGoogle Scholar
  43. 43.
    Deretic, V. 2005. Autophagy in innate and adaptive immunity. Trends Immunol 26:523–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Dittmer, D. P. 2003. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res 63:2010–5.PubMedGoogle Scholar
  45. 45.
    Djerbi, M., V. Screpanti, A. I. Catrina, B. Bogen, P. Biberfeld, and A. Grandien. 1999. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 190:1025–32.PubMedCrossRefGoogle Scholar
  46. 46.
    Duncan, L. M., S. Piper, R. B. Dodd, M. K. Saville, C. M. Sanderson, J. P. Luzio, and P. J. Lehner. 2006. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. Embo J 25:1635–45.PubMedCrossRefGoogle Scholar
  47. 47.
    Edinger, A. L., and C. B. Thompson. 2003. Defective autophagy leads to cancer. Cancer Cell 4:422–4.PubMedCrossRefGoogle Scholar
  48. 48.
    Endres, M. J., C. G. Garlisi, H. Xiao, L. Shan, and J. A. Hedrick. 1999. The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. J Exp Med 189:1993–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Espert, L., M. Denizot, M. Grimaldi, V. Robert-Hebmann, B. Gay, M. Varbanov, P. Codogno, and M. Biard-Piechaczyk. 2006. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 116:2161–72.PubMedCrossRefGoogle Scholar
  50. 50.
    Esteban, M., M. A. Garcia, E. Domingo-Gil, J. Arroyo, C. Nombela, and C. Rivas. 2003. The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation. J Gen Virol 84:1463–70.PubMedCrossRefGoogle Scholar
  51. 51.
    Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529–34.PubMedCrossRefGoogle Scholar
  52. 52.
    Feng, P., J. Park, B. S. Lee, S. H. Lee, R. J. Bram, and J. U. Jung. 2002. Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis. J Virol 76:11491–504.PubMedCrossRefGoogle Scholar
  53. 53.
    Feng, P., C. W. Scott, N. H. Cho, H. Nakamura, Y. H. Chung, M. J. Monteiro, and J. U. Jung. 2004. Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation. Mol Cell Biol 24:3938–48.PubMedCrossRefGoogle Scholar
  54. 54.
    Ferri, K. F., and G. Kroemer. 2001. Organelle-specific initiation of cell death pathways. Nat Cell Biol 3:E255–63.PubMedCrossRefGoogle Scholar
  55. 55.
    Field, N., W. Low, M. Daniels, S. Howell, L. Daviet, C. Boshoff, and M. Collins. 2003. KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 116:3721–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Flano E, H. S., Sample JT, Woodland DL, Blackman MA. 2000. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunology 165:1074–1081.Google Scholar
  57. 57.
    Fodor, W. L., S. A. Rollins, S. Bianco-Caron, R. P. Rother, E. R. Guilmette, W. V. Burton, J. C. Albrecht, B. Fleckenstein, and S. P. Squinto. 1995. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J Virol 69:3889–92.PubMedGoogle Scholar
  58. 58.
    Foster-Cuevas, M., G. J. Wright, M. J. Puklavec, M. H. Brown, and A. N. Barclay. 2004. Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J Virol 78:7667–76.PubMedCrossRefGoogle Scholar
  59. 59.
    Friborg, J., Jr., W. Kong, M. O. Hottiger, and G. J. Nabel. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889–94.PubMedGoogle Scholar
  60. 60.
    Fuld, S., C. Cunningham, K. Klucher, A. J. Davison, and D. J. Blackbourn. 2006. Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol 80:3092–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Furman, M. H., and H. L. Ploegh. 2002. Lessons from viral manipulation of protein disposal pathways. J Clin Invest 110:875–9.PubMedGoogle Scholar
  62. 62.
    Futter, C. E., L. M. Collinson, J. M. Backer, and C. R. Hopkins. 2001. Human VPS34 is required for internal vesicle formation within multivesicular endosomes. J Cell Biol 155:1251–64.PubMedCrossRefGoogle Scholar
  63. 63.
    Gao, Y., P. R. Smith, L. Karran, Q. L. Lu, and B. E. Griffin. 1997. Induction of an exceptionally high-level, nontranslated, Epstein-Barr virus-encoded polyadenylated transcript in the Burkitt's lymphoma line Daudi. J Virol 71:84–94.PubMedGoogle Scholar
  64. 64.
    Garcia-Sastre, A. 2002. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses. Microbes Infect 4:647–55.PubMedCrossRefGoogle Scholar
  65. 65.
    Gerard, C., and B. J. Rollins. 2001. Chemokines and disease. Nat Immunol 2:108–15.PubMedCrossRefGoogle Scholar
  66. 66.
    Glykofrydes, D., H. Niphuis, E. M. Kuhn, B. Rosenwirth, J. L. Heeney, J. Bruder, G. Niedobitek, I. Muller-Fleckenstein, B. Fleckenstein, and A. Ensser. 2000. Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity. J Virol 74:11919–27.PubMedCrossRefGoogle Scholar
  67. 67.
    Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81:2341–64.PubMedGoogle Scholar
  68. 68.
    Graff, J. W., D. N. Mitzel, C. M. Weisend, M. L. Flenniken, and M. E. Hardy. 2002. Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1. J Virol 76:9545–50.PubMedCrossRefGoogle Scholar
  69. 69.
    Grisotto, M. G., A. Garin, A. P. Martin, K. K. Jensen, P. Chan, S. C. Sealfon, and S. A. Lira. 2006. The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest 116:1264–73.PubMedCrossRefGoogle Scholar
  70. 70.
    Grossmann, C., S. Podgrabinska, M. Skobe, and D. Ganem. 2006. Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol 80:7179–85.PubMedCrossRefGoogle Scholar
  71. 71.
    Guasparri, I., S. A. Keller, and E. Cesarman. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199:993–1003.PubMedCrossRefGoogle Scholar
  72. 72.
    Guasparri, I., H. Wu, and E. Cesarman. 2006. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO Rep 7:114–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Guo, H. G., M. Sadowska, W. Reid, E. Tschachler, G. Hayward, and M. Reitz. 2003. Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 77:2631–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Gwack, Y., S. Hwang, H. Byun, C. Lim, J. W. Kim, E. J. Choi, and J. Choe. 2001. Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J Virol 75:6245–8.PubMedCrossRefGoogle Scholar
  75. 75.
    Hahn, A. M., L. E. Huye, S. Ning, J. Webster-Cyriaque, and J. S. Pagano. 2005. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J Virol 79:10040–52.PubMedCrossRefGoogle Scholar
  76. 76.
    He, B., M. Gross, and B. Roizman. 1997. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A 94:843–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Hewitt, E. W., L. Duncan, D. Mufti, J. Baker, P.G. Stevenson, and P. J. Lehner. 2002. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. Embo J 21:2418–29.PubMedCrossRefGoogle Scholar
  78. 78.
    Hirsch, R. L., D. E. Griffin, and J. A. Winkelstein. 1981. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance. J Immunol 127:1740–3.PubMedGoogle Scholar
  79. 79.
    Ho, H. H., D. Du, and M. C. Gershengorn. 1999. The N terminus of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor is necessary for high affinity chemokine binding but not for constitutive activity. J Biol Chem 274:31327–32.PubMedCrossRefGoogle Scholar
  80. 80.
    Honda, K., A. Takaoka, and T. Taniguchi. 2006. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349–60.PubMedCrossRefGoogle Scholar
  81. 81.
    Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6:644–58.PubMedCrossRefGoogle Scholar
  82. 82.
    Honda, K., H. Yanai, A. Takaoka, and T. Taniguchi. 2005. Regulation of the type I IFN induction: a current view. Int Immunol 17:1367–78.PubMedCrossRefGoogle Scholar
  83. 83.
    Hu, F., and J. Nicholas. 2006. Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6. J Virol 80:10874–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Hu, S., C. Vincenz, J. Ni, R. Gentz, and V. M. Dixit. 1997. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem 272:17255–7.PubMedCrossRefGoogle Scholar
  85. 85.
    Huang, Q., A. M. Petros, H. W. Virgin, S. W. Fesik, and E. T. Olejniczak. 2002. Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc Natl Acad Sci U S A 99:3428–33.PubMedCrossRefGoogle Scholar
  86. 86.
    Ishido, S., C. Wang, B. S. Lee, G. B. Cohen, and J. U. Jung. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74:5300–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Jackson, W. T., T. H. Giddings, Jr., M. P. Taylor, S. Mulinyawe, M. Rabinovitch, R. R. Kopito, and K. Kirkegaard. 2005. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 3:e156.PubMedCrossRefGoogle Scholar
  88. 88.
    Joo, C. H., Y. C. Shin, M. Gack, L. Wu, D. Levy, and J. U. Jung. 2007. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi’s Sarcoma-associated herpesvirus viral IRF homology vIRF3. J Virol 81: 8282–8292Google Scholar
  89. 89.
    Jung, J. U., J. K. Choi, A. Ensser, and B. Biesinger. 1999. Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis. Semin Cancer Biol 9:231–9.PubMedCrossRefGoogle Scholar
  90. 90.
    Kannan, K., N. Kaminski, G. Rechavi, J. Jakob-Hirsch, N. Amariglio, and D. Givol. 2001. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene 20:3449–55.PubMedCrossRefGoogle Scholar
  91. 91.
    Kapadia, S. B., B. Levine, S. H. Speck, and H. W. t. Virgin. 2002. Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 17:143–55.PubMedCrossRefGoogle Scholar
  92. 92.
    Kapadia, S. B., H. Molina, V. van Berkel, S. H. Speck, and H. W. t. Virgin. 1999. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation. J Virol 73:7658–70.PubMedGoogle Scholar
  93. 93.
    Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2:675–87.PubMedCrossRefGoogle Scholar
  94. 94.
    Kimball, L. E., C. Casper, D. M. Koelle, R. Morrow, L. Corey, and J. Vieira. 2004. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma. J Infect Dis 189:2016–22.PubMedCrossRefGoogle Scholar
  95. 95.
    Kirchhoff, S., T. Sebens, S. Baumann, A. Krueger, R. Zawatzky, M. Li-Weber, E. Meinl, F. Neipel, B. Fleckenstein, and P. H. Krammer. 2002. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter.J Immunol 168:1226–34.PubMedGoogle Scholar
  96. 96.
    Kledal, T. N., M. M. Rosenkilde, F. Coulin, G. Simmons, A. H. Johnsen, S. Alouani, C. A. Power, H. R. Luttichau, J. Gerstoft, P. R. Clapham, I. Clark-Lewis, T. N. Wells, and T. W. Schwartz. 1997. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277:1656–9.PubMedCrossRefGoogle Scholar
  97. 97.
    Klionsky, D. J. 2005. The molecular machinery of autophagy: unanswered questions. J Cell Sci 118:7–18.PubMedCrossRefGoogle Scholar
  98. 98.
    Korsmeyer, S. J. 1999. BCL-2 gene family and the regulation of programmed cell death. Cancer Res 59:1693s–1700s.PubMedGoogle Scholar
  99. 99.
    Kostavasili, I., A. Sahu, H. M. Friedman, R. J. Eisenberg, G. H. Cohen, and J. D. Lambris. 1997. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J Immunol 158:1763–71.PubMedGoogle Scholar
  100. 100.
    Kotenko, S. V., S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka. 2000. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A 97:1695–700.PubMedCrossRefGoogle Scholar
  101. 101.
    Laude, H., J. Gelfi, L. Lavenant, and B. Charley. 1992. Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J Virol 66:743–9.PubMedGoogle Scholar
  102. 102.
    Leonard, G. T., and G. C. Sen. 1996. Effects of adenovirus E1A protein on interferon-signaling. Virology 224:25–33.PubMedCrossRefGoogle Scholar
  103. 103.
    Levine, B., and J. Yuan. 2005. Autophagy in cell death: an innocent convict? J Clin Invest 115:2679–88.PubMedCrossRefGoogle Scholar
  104. 104.
    Li, M., H. Lee, J. Guo, F. Neipel, B. Fleckenstein, K. Ozato, and J. U. Jung. 1998. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol 72:5433–40.PubMedGoogle Scholar
  105. 105.
    Li, Q., R. Means, S. Lang, and J. U. Jung. 2007. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J Virol 81:2117–27.PubMedCrossRefGoogle Scholar
  106. 106.
    Liang, C., P. Feng, B. Ku, I. Dotan, D. Canaani, B. H. Oh, and J. U. Jung. 2006. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8:688–99.PubMedCrossRefGoogle Scholar
  107. 107.
    Liang, X. H., L. K. Kleeman, H. H. Jiang, G. Gordon, J. E. Goldman, G. Berry, B. Herman, and B. Levine. 1998. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72:8586–96.PubMedGoogle Scholar
  108. 108.
    Lin, R., P. Genin, Y. Mamane, M. Sgarbanti, A. Battistini, W. J. Harrington, Jr., G. N. Barber, and J. Hiscott. 2001. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20:800–11.PubMedCrossRefGoogle Scholar
  109. 109.
    Liszewski, M. K., M. K. Leung, and J. P. Atkinson. 1998. Membrane cofactor protein: importance of N- and O-glycosylation for complement regulatory function. J Immunol 161:3711–8.PubMedGoogle Scholar
  110. 110.
    Liu, L., M. T. Eby, N. Rathore, S. K. Sinha, A. Kumar, and P. M. Chaudhary. 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem 277:13745–51.PubMedCrossRefGoogle Scholar
  111. 111.
    Lodoen, M. B., and L. L. Lanier. 2006. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18:391–8.PubMedCrossRefGoogle Scholar
  112. 112.
    Lodoen, M. B., and L. L. Lanier. 2005. Viral modulation of NK cell immunity. Nat Rev Microbiol 3:59–69.PubMedCrossRefGoogle Scholar
  113. 113.
    Loh, J., Q. Huang, A. M. Petros, D. Nettesheim, L. F. van Dyk, L. Labrada, S. H. Speck, B. Levine, E. T. Olejniczak, and H. W. t. Virgin. 2005. A surface groove essential for viral Bcl-2 function during chronic infection in vivo. PLoS Pathog 1:e10.PubMedCrossRefGoogle Scholar
  114. 114.
    Lorenzo, M. E., J. U. Jung, and H. L. Ploegh. 2002. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J Virol 76:5522–31.PubMedCrossRefGoogle Scholar
  115. 115.
    Lubyova, B., M. J. Kellum, A. J. Frisancho, and P. M. Pitha. 2004. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7.J Biol Chem 279:7643–54.PubMedCrossRefGoogle Scholar
  116. 116.
    Lubyova, B., and P. M. Pitha. 2000. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol 74:8194–201.PubMedCrossRefGoogle Scholar
  117. 117.
    Lundblad, J. R., R. P. Kwok, M. E. Laurance, M. L. Harter, and R. H. Goodman. 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85–8.PubMedCrossRefGoogle Scholar
  118. 118.
    Luttichau, H. R., I. C. Lewis, J. Gerstoft, and T. W. Schwartz. 2001. The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor. Eur J Immunol 31:1217–20.PubMedCrossRefGoogle Scholar
  119. 119.
    Luttichau, H. R., J. Stine, T. P. Boesen, A. H. Johnsen, D. Chantry, J. Gerstoft, and T. W. Schwartz. 2000. A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum. J Exp Med 191:171–80.PubMedCrossRefGoogle Scholar
  120. 120.
    Mansouri, M., J. Douglas, P. P. Rose, K. Gouveia, G. Thomas, R. E. Means, A. V. Moses, and K. Fruh. 2006. Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 108:1932–40.PubMedCrossRefGoogle Scholar
  121. 121.
    Mark, L., W. H. Lee, O. B. Spiller, B. O. Villoutreix, and A. M. Blom. 2006. The Kaposi's sarcoma-associated herpesvirus complement control protein (KCP) binds to heparin and cell surfaces via positively charged amino acids in CCP1-2. Mol Immunol 43:1665–75.PubMedCrossRefGoogle Scholar
  122. 122.
    Matta, H., and P. M. Chaudhary. 2004. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci U S A 101:9399–404.PubMedCrossRefGoogle Scholar
  123. 123.
    McCormick, C., and D. Ganem. 2006. Phosphorylation and function of the kaposin B direct repeats of Kaposi's sarcoma-associated herpesvirus. J Virol 80:6165–70.PubMedCrossRefGoogle Scholar
  124. 124.
    McCormick, C., and D. Ganem. 2005. The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307:739–41.PubMedCrossRefGoogle Scholar
  125. 125.
    McFadden, G., and P. M. Murphy. 2000. Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr Opin Microbiol 3:371–8.PubMedCrossRefGoogle Scholar
  126. 126.
    Means, R. E., J. K. Choi, H. Nakamura, Y. H. Chung, S. Ishido, and J. U. Jung. 2002. Immune evasion strategies of Kaposi's sarcoma-associated herpesvirus. Curr Top Microbiol Immunol 269:187–201.PubMedCrossRefGoogle Scholar
  127. 127.
    Means, R. E., S. Ishido, X. Alvarez, and J. U. Jung. 2002. Multiple endocytic trafficking pathways of MHC class I molecules induced by a Herpesvirus protein. Embo J 21:1638–49.PubMedCrossRefGoogle Scholar
  128. 128.
    Mills, K. R., M. Reginato, J. Debnath, B. Queenan, and J. S. Brugge. 2004. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc Natl Acad Sci U S A 101:3438–43.PubMedCrossRefGoogle Scholar
  129. 129.
    Miwa, T., and W. C. Song. 2001. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int Immunopharmacol 1:445–59.PubMedCrossRefGoogle Scholar
  130. 130.
    Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293–9.PubMedCrossRefGoogle Scholar
  131. 131.
    Molden, J., Y. Chang, Y. You, P. S. Moore, and M. A. Goldsmith. 1997. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem 272:19625–31.PubMedCrossRefGoogle Scholar
  132. 132.
    Moore, P. S., C. Boshoff, R. A. Weiss, and Y. Chang. 1996. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739–44.PubMedCrossRefGoogle Scholar
  133. 133.
    Moorman, N. J., H. W. t. Virgin, and S. H. Speck. 2003. Disruption of the gene encoding the gammaHV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology 307:179–90.PubMedCrossRefGoogle Scholar
  134. 134.
    Moretta, L., G. Ferlazzo, C. Bottino, M. Vitale, D. Pende, M. C. Mingari, and A. Moretta. 2006. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 214:219–28.PubMedCrossRefGoogle Scholar
  135. 135.
    Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138–46.PubMedCrossRefGoogle Scholar
  136. 136.
    Mullick, J., A. Kadam, and A. Sahu. 2003. Herpes and pox viral complement control proteins: 'the mask of self'. Trends Immunol 24:500–7.PubMedCrossRefGoogle Scholar
  137. 137.
    Mullick, J., A. K. Singh, Y. Panse, V. Yadav, J. Bernet, and A. Sahu. 2005. Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol 79:5850–6.PubMedCrossRefGoogle Scholar
  138. 138.
    Murphy, P. M. 2001. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2:116–22.PubMedCrossRefGoogle Scholar
  139. 139.
    Nakamura, H., M. Li, J. Zarycki, and J. U. Jung. 2001. Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol 75:7572–82.PubMedCrossRefGoogle Scholar
  140. 140.
    Neipel, F., J. C. Albrecht, A. Ensser, Y. Q. Huang, J. J. Li, A. E. Friedman-Kien, and B. Fleckenstein. 1997. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 71:839–42.PubMedGoogle Scholar
  141. 141.
    Neipel, F., J. C. Albrecht, and B. Fleckenstein. 1997. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol 71:4187–92.PubMedGoogle Scholar
  142. 142.
    Nicholas, J., V. Ruvolo, J. Zong, D. Ciufo, H. G. Guo, M. S. Reitz, and G. S. Hayward. 1997. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J Virol 71:1963–74.PubMedGoogle Scholar
  143. 143.
    Nicholas, J., V. R. Ruvolo, W. H. Burns, G. Sandford, X. Wan, D. Ciufo, S. B. Hendrickson, H. G. Guo, G. S. Hayward, and M. S. Reitz. 1997. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3:287–92.PubMedCrossRefGoogle Scholar
  144. 144.
    Nishimoto, N., and T. Kishimoto. 2006. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2:619–26.PubMedCrossRefGoogle Scholar
  145. 145.
    Norman, D. G., P. N. Barlow, M. Baron, A. J. Day, R. B. Sim, and I. D. Campbell. 1991. Three-dimensional structure of a complement control protein module in solution. J Mol Biol 219:717–25.PubMedCrossRefGoogle Scholar
  146. 146.
    Oda, E., R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi, and N. Tanaka. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053–8.PubMedCrossRefGoogle Scholar
  147. 147.
    Ojala, P. M., M. Tiainen, P. Salven, T. Veikkola, E. Castanos-Velez, R. Sarid, P. Biberfeld, and T. P. Makela. 1999. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. Cancer Res 59:4984–9.PubMedGoogle Scholar
  148. 148.
    Osborne, J., P. S. Moore, and Y. Chang. 1999. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol 60:921–7.PubMedCrossRefGoogle Scholar
  149. 149.
    Pappworth, I. Y., E. C. Wang, and M. Rowe. 2007. The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing. J Virol 81:474–82.PubMedCrossRefGoogle Scholar
  150. 150.
    Park, J., T. Seo, S. Hwang, D. Lee, Y. Gwack, and J. Choe. 2000. The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J Virol 74:11977–82.PubMedCrossRefGoogle Scholar
  151. 151.
    Parker, A. K., S. Parker, W. M. Yokoyama, J. A. Corbett, and R. M. Buller. 2007. Induction of Natural Killer Cell Responses by Ectromelia Virus Controls Infection. J Virol 81(8): 4070–9.Google Scholar
  152. 152.
    Parry, C. M., J. P. Simas, V. P. Smith, C. A. Stewart, A. C. Minson, S. Efstathiou, and A. Alcami. 2000. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191:573–8.PubMedCrossRefGoogle Scholar
  153. 153.
    Pattingre, S., A. Tassa, X. Qu, R. Garuti, X. H. Liang, N. Mizushima, M. Packer, M. D. Schneider, and B. Levine. 2005. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122:927–39.PubMedCrossRefGoogle Scholar
  154. 154.
    Perry, S. T., and T. Compton. 2006. Kaposi's sarcoma-associated herpesvirus virions inhibit interferon responses induced by envelope glycoprotein gpK8.1. J Virol 80:11105–14.PubMedCrossRefGoogle Scholar
  155. 155.
    Pestka, S., C. D. Krause, and M. R. Walter. 2004. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202:8–32.PubMedCrossRefGoogle Scholar
  156. 156.
    Polster, B. M., J. Pevsner, and J. M. Hardwick. 2004. Viral Bcl-2 homologs and their role in virus replication and associated diseases. Biochim Biophys Acta 1644:211–27.PubMedCrossRefGoogle Scholar
  157. 157.
    Poppers, J., M. Mulvey, D. Khoo, and I. Mohr. 2000. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J Virol 74:11215–21.PubMedCrossRefGoogle Scholar
  158. 158.
    Pozharskaya, V. P., L. L. Weakland, J. C. Zimring, L. T. Krug, E. R. Unger, A. Neisch, H. Joshi, N. Inoue, and M. K. Offermann. 2004. Short duration of elevated vIRF-1 expression during lytic replication of human herpesvirus 8 limits its ability to block antiviral responses induced by alpha interferon in BCBL-1 cells. J Virol 78:6621–35.PubMedCrossRefGoogle Scholar
  159. 159.
    Proudfoot, A. E., S. Fritchley, F. Borlat, J. P. Shaw, F. Vilbois, C. Zwahlen, A. Trkola, D. Marchant, P. R. Clapham, and T. N. Wells. 2001. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J Biol Chem 276:10620–6.PubMedCrossRefGoogle Scholar
  160. 160.
    Reading, P. C., P. G. Whitney, D. P. Barr, M. J. Smyth, and A. G. Brooks. 2006. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection. Eur J Immunol 36:897–905.PubMedCrossRefGoogle Scholar
  161. 161.
    Rezaee, S. A., J. A. Gracie, I. B. McInnes, and D. J. Blackbourn. 2005. Inhibition of neutrophil function by the Kaposi's sarcoma-associated herpesvirus vOX2 protein. Aids 19:1907–10.PubMedCrossRefGoogle Scholar
  162. 162.
    Rivas, C., A. E. Thlick, C. Parravicini, P. S. Moore, and Y. Chang. 2001. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 75:429–38.PubMedCrossRefGoogle Scholar
  163. 163.
    Ronco, L. V., A. Y. Karpova, M. Vidal, and P. M. Howley. 1998. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061–72.PubMedCrossRefGoogle Scholar
  164. 164.
    Rubant, S., R. J. Ludwig, J. Pfeffer, P. Schulze-Johann, R. Kaufmann, J. M. Pfeilschifter, W. H. Boehncke, and H. H. Radeke. 2006. Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivo. Exp Dermatol 15:634–42.PubMedCrossRefGoogle Scholar
  165. 165.
    Russo, J. J., R. A. Bohenzky, M. C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93:14862–7.PubMedCrossRefGoogle Scholar
  166. 166.
    Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875–83.PubMedCrossRefGoogle Scholar
  167. 167.
    Sanchez, G., R. M. Pinto, H. Vanaclocha, and A. Bosch. 2002. Molecular characterization of hepatitis a virus isolates from a transcontinental shellfish-borne outbreak. J Clin Microbiol 40:4148–55.PubMedCrossRefGoogle Scholar
  168. 168.
    Sarid, R., T. Sato, R. A. Bohenzky, J. J. Russo, and Y. Chang. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 3:293–8.PubMedCrossRefGoogle Scholar
  169. 169.
    Schoneberg, T., G. Schultz, and T. Gudermann. 1999. Structural basis of G protein-coupled receptor function. Mol Cell Endocrinol 151:181–93.PubMedCrossRefGoogle Scholar
  170. 170.
    Schwarz, M., and P. M. Murphy. 2001. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol 167:505–13.PubMedGoogle Scholar
  171. 171.
    Searles, R. P., E. P. Bergquam, M. K. Axthelm, and S. W. Wong. 1999. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 73:3040–53.PubMedGoogle Scholar
  172. 172.
    Seo, T., J. Park, and J. Choe. 2005. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling. Cancer Res 65:1738–47.PubMedCrossRefGoogle Scholar
  173. 173.
    Seo, T., J. Park, D. Lee, S. G. Hwang, and J. Choe. 2001. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol 75:6193–8.PubMedCrossRefGoogle Scholar
  174. 174.
    Seo, T., J. Park, C. Lim, and J. Choe. 2004. Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus. Oncogene 23:6146–55.PubMedCrossRefGoogle Scholar
  175. 175.
    Shin, Y. C., H. Nakamura, X. Liang, P. Feng, H. Chang, T. F. Kowalik, and J. U. Jung. 2006. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol 80:2257–66.PubMedCrossRefGoogle Scholar
  176. 176.
    Sirianni, M. C., F. Libi, M. Campagna, D. Rossi, D. Capello, G. Sciaranghella, A. Carbone, C. Simonelli, P. Monini, G. Gaidano, and B. Ensoli. 2005. Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development. Br J Haematol 130:92–5.PubMedCrossRefGoogle Scholar
  177. 177.
    Sirianni, M. C., L. Vincenzi, S. Topino, A. Giovannetti, F. Mazzetta, F. Libi, D. Scaramuzzi, M. Andreoni, E. Pinter, S. Baccarini, G. Rezza, P. Monini, and B. Ensoli. 2002. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. Eur J Immunol 32:2711–20.PubMedCrossRefGoogle Scholar
  178. 178.
    Sodhi, A., R. Chaisuparat, J. Hu, A. K. Ramsdell, B. D. Manning, E. A. Sausville, E. T. Sawai, A. Molinolo, J. S. Gutkind, and S. Montaner. 2006. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10:133–43.PubMedCrossRefGoogle Scholar
  179. 179.
    Sodhi, A., S. Montaner, and J. S. Gutkind. 2004. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis? Faseb J 18:422–7.PubMedCrossRefGoogle Scholar
  180. 180.
    Sodhi, A., S. Montaner, V. Patel, J. J. Gomez-Roman, Y. Li, E. A. Sausville, E. T. Sawai, and J. S. Gutkind. 2004. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci U S A 101:4821–6.PubMedCrossRefGoogle Scholar
  181. 181.
    Sozzani, S., W. Luini, G. Bianchi, P. Allavena, T. N. Wells, M. Napolitano, G. Bernardini, A. Vecchi, D. D'Ambrosio, D. Mazzeo, F. Sinigaglia, A. Santoni, E. Maggi, S. Romagnani, and A. Mantovani. 1998. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 92:4036–9.PubMedGoogle Scholar
  182. 182.
    Spiller, O. B., D. J. Blackbourn, L. Mark, D. G. Proctor, and A. M. Blom. 2003. Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus. J Biol Chem 278:9283–9.PubMedCrossRefGoogle Scholar
  183. 183.
    Spiller, O. B., M. Robinson, E. O'Donnell, S. Milligan, B. P. Morgan, A. J. Davison, and D. J. Blackbourn. 2003. Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein. J Virol 77:592–9.PubMedCrossRefGoogle Scholar
  184. 184.
    Spriggs, M. K. 1996. One step ahead of the game: viral immunomodulatory molecules. Annu Rev Immunol 14:101–30.PubMedCrossRefGoogle Scholar
  185. 185.
    Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu Rev Biochem 67:227–64.PubMedCrossRefGoogle Scholar
  186. 186.
    Stetson, D. B., and R. Medzhitov. 2006. Type I interferons in host defense. Immunity 25:373–81.PubMedCrossRefGoogle Scholar
  187. 187.
    Stevenson, P. G., S. Efstathiou, P. C. Doherty, and P. J. Lehner. 2000. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci U S A 97:8455–60.PubMedCrossRefGoogle Scholar
  188. 188.
    Stevenson, P. G., J. S. May, X. G. Smith, S. Marques, H. Adler, U. H. Koszinowski, J. P. Simas, and S. Efstathiou. 2002. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 3:733–40.PubMedGoogle Scholar
  189. 189.
    Stine, J. T., C. Wood, M. Hill, A. Epp, C. J. Raport, V. L. Schweickart, Y. Endo, T. Sasaki, G. Simmons, C. Boshoff, P. Clapham, Y. Chang, P. Moore, P. W. Gray, and D. Chantry. 2000. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 95:1151–7.PubMedGoogle Scholar
  190. 190.
    Stoiber, H., C. Pinter, A. G. Siccardi, A. Clivio, and M. P. Dierich. 1996. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J Exp Med 183:307–10.PubMedCrossRefGoogle Scholar
  191. 191.
    Sun, Q., H. Matta, and P. M. Chaudhary. 2005. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat. Retrovirology 2:9.PubMedCrossRefGoogle Scholar
  192. 192.
    Sun, Q., H. Matta, and P. M. Chaudhary. 2003. The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation. Blood 101:1956–61.PubMedCrossRefGoogle Scholar
  193. 193.
    Sun, Q., H. Matta, G. Lu, and P. M. Chaudhary. 2006. Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation. Oncogene 25:2717–26.PubMedCrossRefGoogle Scholar
  194. 194.
    Sun, Q., S. Zachariah, and P. M. Chaudhary. 2003. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J Biol Chem 278:52437–45.PubMedCrossRefGoogle Scholar
  195. 195.
    Talloczy, Z., H. W. t. Virgin, and B. Levine. 2006. PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2:24–9.PubMedGoogle Scholar
  196. 196.
    Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J. L. Bodmer, M. Schroter, C. Scaffidi, P. H. Krammer, M. E. Peter, and J. Tschopp. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517–21.PubMedCrossRefGoogle Scholar
  197. 197.
    Thorburn, J., F. Moore, A. Rao, W. W. Barclay, L. R. Thomas, K. W. Grant, S. D. Cramer, and A. Thorburn. 2005. Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells. Mol Biol Cell 16:1189–99.PubMedCrossRefGoogle Scholar
  198. 198.
    Tomescu, C., W. K. Law, and D. H. Kedes. 2003. Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. J Virol 77:9669–84.PubMedCrossRefGoogle Scholar
  199. 199.
    Tortorella, D., B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu Rev Immunol 18:861–926.PubMedCrossRefGoogle Scholar
  200. 200.
    Upton, C., K. Mossman, and G. McFadden. 1992. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258:1369–72.PubMedCrossRefGoogle Scholar
  201. 201.
    van Berkel, V., B. Levine, S. B. Kapadia, J. E. Goldman, S. H. Speck, and H. W. t. Virgin. 2002. Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis. J Clin Invest 109:905–14.PubMedGoogle Scholar
  202. 202.
    van Boxel-Dezaire, A. H., M. R. Rani, and G. R. Stark. 2006. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25:361–72.PubMedCrossRefGoogle Scholar
  203. 203.
    Vilcek, J. 2003. Novel interferons. Nat Immunol 4:8–9.PubMedCrossRefGoogle Scholar
  204. 204.
    Vilcek, J. T. 1996. Cytokines in 1995. Cytokine Growth Factor Rev 7:103–6.PubMedCrossRefGoogle Scholar
  205. 205.
    Virgin, H. W. t., P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71:5894–904.PubMedGoogle Scholar
  206. 206.
    Wang, H. W., T. V. Sharp, A. Koumi, G. Koentges, and C. Boshoff. 2002. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. Embo J 21:2602–15.PubMedCrossRefGoogle Scholar
  207. 207.
    Watanabe, I., T. M. Ross, S. Tamura, T. Ichinohe, S. Ito, H. Takahashi, H. Sawa, J. Chiba, T. Kurata, T. Sata, and H. Hasegawa. 2003. Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine 21:4532–8.PubMedCrossRefGoogle Scholar
  208. 208.
    Weaver, B. K., K. P. Kumar, and N. C. Reich. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol Cell Biol 18:1359–68.PubMedGoogle Scholar
  209. 209.
    Webb, L. M., and A. Alcami. 2005. Virally encoded chemokine binding proteins. Mini Rev Med Chem 5:833–48.PubMedCrossRefGoogle Scholar
  210. 210.
    Webb, L. M., V. P. Smith, and A. Alcami. 2004. The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans. Faseb J 18:571–3.PubMedGoogle Scholar
  211. 211.
    Weber, K. S., H. J. Grone, M. Rocken, C. Klier, S. Gu, R. Wank, A. E. Proudfoot, P. J. Nelson, and C. Weber. 2001. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur J Immunol 31:2458–66.PubMedCrossRefGoogle Scholar
  212. 212.
    Wright, G. J., H. Cherwinski, M. Foster-Cuevas, G. Brooke, M. J. Puklavec, M. Bigler, Y. Song, M. Jenmalm, D. Gorman, T. McClanahan, M. R. Liu, M. H. Brown, J. D. Sedgwick, J. H. Phillips, and A. N. Barclay. 2003. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol 171:3034–46.PubMedGoogle Scholar
  213. 213.
    Yu, Y., S. E. Wang, and G. S. Hayward. 2005. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22:59–70.PubMedCrossRefGoogle Scholar
  214. 214.
    Zhu, F. X., S. M. King, E. J. Smith, D. E. Levy, and Y. Yuan. 2002. A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc Natl Acad Sci U S A 99:5573–8.PubMedCrossRefGoogle Scholar
  215. 215.
    Zhu, F. X., and Y. Yuan. 2003. The ORF45 protein of Kaposi's sarcoma-associated herpesvirus is associated with purified virions. J Virol 77:4221–30.PubMedCrossRefGoogle Scholar
  216. 216.
    Zimring, J. C., S. Goodbourn, and M. K. Offermann. 1998. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 72:701–7.PubMedGoogle Scholar
  217. 217.
    Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • Chengyu Liang
  • Hyera Lee
  • Liguo Wu
  • Pinghui Feng
  • Jae U. Jung
    • 1
  1. 1.Department of Molecular Microbiology and ImmunologyUniversity of Sourthern CaliforniaLos Angeles

Personalised recommendations